Clinical trial
Tocotrienols in Parkinson's Disease (PD): A Pilot, Randomised, Placebo-controlled Trial
NCT04491383 is registered in ClinicalTrials.gov with National Neuroscience Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tocotrienols in Parkinson's Disease (PD): A Pilot, Randomised, Placebo-controlled Trial
- Lead sponsor
- National Neuroscience Institute
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- April 1, 2021
- Completion date
- July 31, 2027
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
neuro-degenerative disease, parkinson disease